Gilead Sciences
Gilead Sciences, Inc., a leading biopharmaceutical company headquartered in the United States, has been at the forefront of innovative healthcare since its founding in 1987. With a strong presence in regions such as Europe and Asia, Gilead focuses on the research, development, and commercialisation of antiviral drugs, particularly for HIV, hepatitis B, hepatitis C, and influenza.
The company is renowned for its groundbreaking therapies, including Biktarvy and Harvoni, which have transformed the treatment landscape for chronic viral infections. Gilead's commitment to advancing medicine is underscored by its significant achievements, including multiple FDA approvals and a robust pipeline of investigational therapies. As a key player in the biopharmaceutical industry, Gilead Sciences continues to shape the future of healthcare through its dedication to scientific innovation and patient care.
+19 vs industry average
Gilead Sciences’s score of 57 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Gilead Sciences?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Gilead Sciences's reported carbon emissions
In 2024, Gilead Sciences reported total greenhouse gas emissions of approximately 1.05 billion kg CO2e. This figure includes 53,856,000 kg CO2e from Scope 1 (direct emissions), 17,137,000 kg CO2e from Scope 2 (indirect emissions from energy consumption), and 998,099,000 kg CO2e from Scope 3 (indirect emissions across the value chain). Gilead has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 emissions by 46% by 2030, using a 2019 baseline. Additionally, the company has committed to a 15% reduction in absolute Scope 3 emissions over the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are designed to support global efforts to limit warming to 1.5°C. The company is also striving for carbon net-zero operational GHG emissions by 2030, encompassing both Scope 1 and 2 emissions. Gilead's environmental strategy is focused on significant reductions in greenhouse gas emissions, reflecting its commitment to sustainability and climate action.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Gilead Sciences’s Climate Goals (2030 & 2050)
2 goals2030
Gilead has a net-zero operations ambition (Scope 1 and 2) by…
Gilead has a net-zero operations ambition (Scope 1 and 2) by 2030.
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 2 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
10 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsFrequently asked questions
Common questions about Gilead Sciences’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project